The global Digital Breast Tomosynthesis Equipment Market is estimated to be valued at US$ 2,400.6 Mn or Mn in 2023 and is expected to exhibit a CAGR of 15.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Digital breast tomosynthesis is an advanced mammography technique utilizing low dose x-rays and computer processing to produce 3D images of breasts. It can identify subtle lesions missed on conventional 2D mammography and helps in accurate diagnosis by eliminating overlapping tissue.
Market key trends:
One of the key trends spurring the market growth is the rising adoption of digital breast tomosynthesis in developed markets owing to its advantages over digital mammography. For instance, a study published in Radiology revealed that tomosynthesis increased invasive cancer detection rate by 40% and reduced unnecessary breast biopsies by 15%. Furthermore, continuous technological enhancements such as combination of tomosynthesis with diagnostic imaging and developments of AI-driven breast screening solutions are also boosting the market. However, high installation and maintenance costs of digital breast tomosynthesis equipment restrict the market in price-sensitive developing regions.
Market key trends:
One of the key trends in the digital breast tomosynthesis equipment market is the growing adoption of 3D screening technology for breast cancer detection. Digital breast tomosynthesis (DBT) provides ultra-high resolution 3D images of the breasts by taking multiple x-ray exposures from different angles and reconstructing them to produce breast tissue images. This technology has shown improved detection rates for invasive breast cancers and have significantly reduced call-back rates for additional imaging tests compared to traditional 2D mammography. With its increased accuracy in identifying small lesions and masses, the use of DBT has grown substantially in the past few years for breast screening purposes.
SWOT Analysis
Strengths: DBT offers improved accuracy compared to 2D mammography with a lower false positive rate. It provides tomosynthesis reconstruction of the breast which reveals more information than a single projection view of 2D mammography.
Weaknesses: DBT machines are more expensive compared to standard mammography units. The tomosynthesis scans require higher radiation dose for patients compared to 2D mammography.
Opportunities: Increasing awareness about breast cancer screening and rising healthcare expenditure in developing countries provide major opportunities. Untapped growth potential exists in Asia Pacific and Latin American markets.
Threats: High capital requirement for upgrading existing mammography equipment to DBT poses challenges. Reimbursement issues and budgetary constraints in some countries also threaten market growth prospects.
Key Takeaways
The global digital breast tomosynthesis equipment market is expected to witness high growth, exhibiting CAGR of 15.% over the forecast period, due to increasing awareness about early breast cancer detection and benefits of DBT technology.
The global market size for digital breast tomosynthesis equipment was valued at US$ 2,400.6 Mn in 2023 and is anticipated to reach over US$ 6,500 Mn by 2030. North America currently dominates the market due to favorable reimbursement policies and growing adoption of advanced breast cancer screening practices in the region. Asia Pacific is expected to be the fastest growing market owing to rising healthcare spending and increasing patient pool.
Key players operating in the digital breast tomosynthesis equipment market share include Hologic, Inc., Internazionale Medico Scientifica-S.R.L, GE Healthcare, Siemens Healthineers, Fujifilm Corporation, Planmed OY, Trivitron Healthcare, Varex Imaging Corporation, and Analogic Corporation. Market players are focusing on new product launches and expanding in emerging markets through collaborations.